Labs / Assays & in vitro testing
4TEEN4 Pharmaceuticals GmbH
Hennigsdorf, Germany · 4teen4.de
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
4TEEN4 Pharmaceuticals GmbH develops a biomarker-driven therapy for shock centered on circulating DPP3 (cDPP3) and its antibody invobenitug (procizumab). The company is headquartered in Hennigsdorf, Germany, and focuses on critically ill patients, especially those with cardiogenic shock.
They take quote requests by email.
What they offer
Therapy development for shock
Advances a first-in-class therapy designed to neutralize circulating DPP3 and address the underlying drivers of shock.
Biomarker-driven patient selection
Uses cDPP3 levels to identify high-risk patients and support patient stratification for shock treatment development.
Diagnostic development for cDPP3
Develops a diagnostic approach based on measuring circulating DPP3 as a prognostic marker in shock.
What they work on
- Modalities
- Antibody, Peptide
- Therapeutic areas
- shock, cardiogenic shock, critical care, sepsis, trauma, burns, major surgery
- Sites
- Hennigsdorf, Germany
- Serves
- U.S., Europe
- Address
- Neuendorfstrasse 16B 16761 Hennigsdorf
Similar labs. 3C Therapeutics, Abeomics, ACM Global Laboratories, Alphalyse
Found in a contract services directory. Listing built from 4teen4.de. Work here? Claim this listing.